Background: Hepatic hemangiomas are the most common benign liver tumors, and the management of giant hepatic hemangioma (GHH) is still in controversial. The aim of this meta-analysis was to compare the postoperative outcomes of enucleation versus anatomic resection for GHH. Methods: PubMed, Embase, Web of Science, and the Cochrane Library were searched from January 1988 to December 2015 to identify studies comparing the outcomes of enucleation versus anatomic resection for GHH. Finally, we performed this meta-analysis using the Review Manager 5.3 software, and the results were presented as risk ratio (RR) or mean difference (MD) with corresponding 95% confidence interval (CI). The major limitation is that all data were derived from nonrandomized studies, and we cannot exclude potential selection bias. Results: Nine studies involving 1,185 patients were included. The results showed that there was a lower incidence of complications (RR = 0.66, 95% CI 0.52 to 0.84, I2 = 0%, p = 0.0007); no incidents of death occurred among the 9 included trials. Blood loss (MD = -419.07 mL, 95% CI -575.04 to -263.09, I2 = 83%, p < 0.00001), duration of surgery (MD = -23.5 min, 95% CI -45.28 to -1.74, I2 = 0%, p = 0.03), and length of hospital stay (MD = -1.59 days, 95% CI -3.06 to -0.13, I2 = 0%, p = 0.03) were much lower in the enucleation group. Conclusions: GHH can be removed safely by either enucleation or anatomic resection. Enucleation can preserve more hepatic parenchyma and reduce postoperative complications, which is why it should be the preferred surgical procedure for suitable lesions.

1.
Choi BY, Nguyen MH: The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 2005;39:401-412.
2.
Duxbury MS, Garden OJ: Giant haemangioma of the liver: observation or resection? Dig Surg 2010;27:7-11.
3.
Bajenaru N, Balaban V, Savulescu F, Campeanu I, Patrascu T: Hepatic hemangioma - review. J Med Life 2015;8(spec issue):4-11.
4.
Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, DeMatteo RP: Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003;197:392-402.
5.
Schnelldorfer T, Ware AL, Smoot R, Schleck CD, Harmsen WS, Nagorney DM: Management of giant hemangioma of the liver: resection versus observation. J Am Coll Surg 2010;211:724-730.
6.
Gedaly R, Pomposelli JJ, Pomfret EA, Lewis WD, Jenkins RL: Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg 1999;134:407-411.
7.
Di Carlo I, Koshy R, Al Mudares S, Ardiri A, Bertino G, Toro A: Giant cavernous liver hemangiomas: is it the time to change the size categories? Hepatobiliary Pancreat Dis Int 2016;15:21-29.
8.
Hall GW: Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001;112:851-862.
9.
Alper A, Ariogul O, Emre A, Uras A, Okten A: Treatment of liver hemangiomas by enucleation. Arch Surg 1988;123:660-661.
10.
Demiryürek H, Alabaz O, Ağdemir D, Sungur I, Erkoçak EU, Akinoğlu A, Alparslan A, Zorludemir S: Symptomatic giant cavernous haemangioma of the liver: is enucleation a safe method? A single institution report. HPB Surg 1997;10:299-304.
11.
Hamaloglu E, Altun H, Ozdemir A, Ozenc A: Giant liver hemangioma: therapy by enucleation or liver resection. World J Surg 2005;29:890-893.
12.
Singh RK, Kapoor S, Sahni P, Chattopadhyay TK: Giant haemangioma of the liver: is enucleation better than resection? Ann R Coll Surg Engl 2007;89:490-493.
13.
Qiu J, Chen S, Wu H: Quality of life can be improved by surgical management of giant hepatic haemangioma with enucleation as the preferred option. HPB (Oxford) 2015;17:490-494.
14.
Giuliante F, Ardito F, Vellone M, Giordano M, Ranucci G, Piccoli M, Giovannini I, Chiarla C, Nuzzo G: Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients. Am J Surg 2011;201:741-748.
15.
Zhang W, Huang ZY, Ke CS, Wu C, Zhang ZW, Zhang BX, Chen YF, Zhang WG, Zhu P, Chen XP: Surgical treatment of giant liver hemangioma larger than 10 cm: a single center's experience with 86 patients. Medicine (Baltimore) 2015;94:e1420.
16.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 2009;3:e123-e130.
17.
Reeves BC, Higgins JP, Ramsay C, Shea B, Tugwell P, Wells GA: An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions. Res Synth Methods 2013;4:1-11.
18.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
19.
Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
20.
Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
21.
Lerner SM, Hiatt JR, Salamandra J, Chen PW, Farmer DG, Ghobrial RM, Busuttil RW: Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg 2004;139:818-821.
22.
Xiao N, Yu Q, Duan W, Dong J: Surgical management of giant hemangioma of the liver: enucleation versus hepatectomy. Chin J Gen Surg 2015;30:436-439.
23.
Ho HY, Wu TH, Yu MC, Lee WC, Chao TC, Chen MF: Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J 2012;35:70-78.
24.
Hoekstra LT, Bieze M, Erdogan D, Roelofs JJ, Beuers UH, van Gulik TM: Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol 2013;7:263-268.
25.
Zimmermann A, Baer HU: Fibrous tumor-liver interface in large hepatic neoplasms: its significance for tumor resection and enucleation. Liver Transpl Surg 1996;2:192-199.
26.
Ozden I, Emre A, Alper A, Tunaci M, Acarli K, Bilge O, Tekant Y, Ariogul O: Long-term results of surgery for liver hemangiomas. Arch Surg 2000;135:978-981.
27.
Dong J: Precision liver surgery. Chin J Dig Surg 2014;13:405-411.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.